+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Avanir Pharmaceuticals Inc  - logo

Avanir Pharmaceuticals focuses on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. Avanir Pharmaceuticals was founded in 1988 and is headquartered in Aliso Viejo, California.

Schizophrenia (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Schizophrenia (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 513 Pages
From
From
From
From
From
Schizophrenia - Pipeline Insight, 2021 - Product Thumbnail Image

Schizophrenia - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 120 Pages
From
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 Pages
From
From
Migraine (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Migraine (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 363 Pages
From
From
Major Depressive Disorder - Pipeline Insight, 2021 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 120 Pages
From
From
Sigma-1 receptor agonists - Pipeline Insight, 2022 - Product Thumbnail Image

Sigma-1 receptor agonists - Pipeline Insight, 2022

  • Drug Pipelines
  • January 2022
  • 60 Pages
From
Serotonin Transporter Inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

Serotonin Transporter Inhibitor - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Sigma Receptor Agonist - Pipeline Insight, 2022 - Product Thumbnail Image

Sigma Receptor Agonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Loading Indicator